Purchases and Sales Made in Q3 2022 in Immix Biopharma, Inc. (IMMX)
This table provides information about the institutional ownership of Immix Biopharma, Inc. (IMMX) during Q3 2022. The information is specifically focused on institutions that hold shares of Immix Biopharma, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
54.2K+ 106.51% |
$73.7K - $165K
|
105K
$231K
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
27.1KNew |
$36.8K - $82.5K
|
27.1K
$59.5K
|
|
Nov 14, 2022
Q3 2022
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
19.2KNew |
$26K - $58.4K
|
19.2K
$42.1K
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
7.67K+ 176.78% |
$10.4K - $23.4K
|
12K
$26.4K
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
BUY
|
- |
4.4K+ 11.41% |
$5.98K - $13.4K
|
43K
$94.5K
|
|
Nov 14, 2022
Q3 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
3.44K+ 4.69% |
$4.67K - $10.5K
|
76.8K
$169K
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
250New |
$340 - $763
|
250
$550
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
3New |
$4.08 - $9.15
|
3
$6.6
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-34- 48.57% |
$46.2 - $104
|
36
$79.2
|
|
Oct 13, 2022
Q3 2022
|
Pvg Asset Management Corp
Golden, CO |
SELL
|
- |
-20KClosed |
$27.2K - $61K
|
0
$0
|